Functional genomics to understand the Fusarium resistance response of wheat
- Nachwachsende Rohstoffe und neue Technologien
- Lebensmittel, Ernährung, Gesundheit
- Biotechnologie
- Forschungscluster "Pflanzen"
Abstract
The goal of this project part is to use near isogenic lines differing in particular QTLs and new material developed during the course of the project for functional genomics approaches. The aim is to identify differences in gene expression and allelic differences, to identify candidate genes that are causal for the QTL effect. The tools used will be advanced Affymetrix microarrays to utilization of high throughput second generation sequencing. A well characterized doubled haploid population of wheat will be used to map gene expression (eQTL mapping) and compare eQTLs with phenotypic trait QTLs. Furthermore a newly developed TILLING population in a highly Fusarium resistant wheat background will be used for gene validation. Once established and proven to work for Fusarium infection, virus induced gene silencing (VIGS) will be utilized as prescreen (in collaboration with Dr. Patrick Schweizer, IPK Gatersleben). Promising targets will be provided to PP12 for overexpression studies in transgenic wheat.
- Fusarium head blight
- gene expression
- kandidate gene
- resistance
- wheat
Publications
Gene expression analysis of related wheat lines with contrasting levels of head blight resistance after Fusarium graminearum inoculation
Autoren: Steiner Barbara, Apinun Limmongkon, Katharina Schiessl, Marc Lemmens, Hayan Jia, Gary Muehlbauer, Alexandra Posekany, David P. Kreil, Hermann Buerstmayr Jahr: 2010
Conference & Workshop proceedings, paper, abstract
Project staff
Hermann Bürstmayr
Univ.Prof. Dipl.-Ing. Dr.nat.techn. Hermann Bürstmayr
hermann.buerstmayr@boku.ac.at
Tel: +43 1 47654-97101, 97102
BOKU Project Leader
01.02.2009 - 28.02.2019
Barbara Steiner
Dipl.-Ing. Dr. Barbara Steiner
barbara.steiner@boku.ac.at
Tel: +43 1 47654-97105
Project Staff
01.02.2009 - 28.02.2019
BOKU partners
External partners
HELMHOLTZ ZENTRUM MUENCHEN – DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT (GMBH)
Dr. Klaus Mayer
partner